VEDOLIZUMAB and MALAISE

4,083 reports of this reaction

1.8% of all VEDOLIZUMAB reports

#11 most reported adverse reaction

Overview

MALAISE is the #11 most commonly reported adverse reaction for VEDOLIZUMAB, manufactured by Takeda Pharmaceuticals America, Inc.. There are 4,083 FDA adverse event reports linking VEDOLIZUMAB to MALAISE. This represents approximately 1.8% of all 224,197 adverse event reports for this drug.

VEDOLIZUMAB has an overall safety score of 88 out of 100. Patients taking VEDOLIZUMAB who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE4,083 of 224,197 reports

MALAISE is a less commonly reported adverse event for VEDOLIZUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of VEDOLIZUMAB

In addition to malaise, the following adverse reactions have been reported for VEDOLIZUMAB:

OFF LABEL USE — 21,828 reports
COLITIS ULCERATIVE — 14,515 reports
CROHN^S DISEASE — 10,631 reports
DRUG INEFFECTIVE — 9,419 reports
DIARRHOEA — 8,171 reports
ABDOMINAL PAIN — 6,952 reports
FATIGUE — 5,981 reports
HAEMATOCHEZIA — 5,657 reports
FREQUENT BOWEL MOVEMENTS — 4,906 reports
ARTHRALGIA — 4,447 reports

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

0XYGEN ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DIPHENHYDRAMINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

Frequently Asked Questions

Does VEDOLIZUMAB cause MALAISE?

MALAISE has been reported as an adverse event in 4,083 FDA reports for VEDOLIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with VEDOLIZUMAB?

MALAISE accounts for approximately 1.8% of all adverse event reports for VEDOLIZUMAB, making it a notable side effect.

What should I do if I experience MALAISE while taking VEDOLIZUMAB?

If you experience malaise while taking VEDOLIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

VEDOLIZUMAB Full Profile All Drugs Causing MALAISE Takeda Pharmaceuticals America, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.